Bristol Myers Squibb Impact Investors
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Invests into
.png)
Last Funding Type:
Post-IPO Debt
Funding Status:
Post-IPO Debt
Headquarters:
New York, New York, United States
Founded Date:
1887-01-01
Investor Type:
Technology - oriented Investor with Venture Investment Focus
Investment Stage:
Early Stage Venture, Venture
Last Funding Date:
2022-02-15
Total Funding:
6080000000
Technology:
Biotechnology, Health Care, Medical, Pharmaceutical
Employee Number:
10001+
Number Of Exists:
11
Acquisitions Number:
Made Acquisitions
Estimated Revenue:
$1B to $10B
Investors Number:
13
Industry:
Longevity Biomarkers